Diabetes Insulin Injection Pen

FDA approves 1st rapid-acting insulin

FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and children with diabetes, the agency announced Friday. Like i

KIRO-TV · 5h

FDA approves first rapid-acting insulin

According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in people with diabetes.

Business Insider · 8h

FDA approves Sanofi biosimilar product for treatment of diabetes

The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric

MarketWatch · 9h

FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes

Agency Continues Efforts to Increase Access to Insulin Treatment Options SILVER SPRING, Md., /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients with diabetes mellitus.

Seeking Alpha on MSN · 7h

Sanofi gets FDA approval for NovoLog insulin biosimilar

Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children with diabetes mellitus.

Healio6h

FDA approves subcutaneous Merilog for glycemic control in diabetes

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Medscape6d

A Review of 20 Years' Experience With the Novopen Family of Insulin Injection Devices

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

11h

Does Medicare Cover Ozempic?

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Healio12h

Automated insulin delivery lowers HbA1c, improves time in range in type 2 diabetes

Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...

Half of adults with Type 1 diabetes say condition limits spontaneity

A recent survey found that more than half of adults living with Type 1 diabetes believe the condition limits their ability to be spontaneous ...

Over half of Type 1 diabetes patients feel their daily lives are restricted, survey shows

A recent survey found that more than half of people living with Type 1 diabetes say the condition has an impact on their ...

Tech advances ease lives of type 1 diabetic children and their parents

Insulin pumps and CGMS provide greater flexibility, improved blood sugar control, and better quality of life for children and ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results